Wolff-Vorbeck G, Hackl W, Fenning S, Krawinkel U, Lührmann R, Peter H H, Schlesier M
Abt. Rheumatologie und Klinische Immunologie, Medizinische Klinik, Freiburg, Germany.
Clin Exp Immunol. 1994 Mar;95(3):378-84. doi: 10.1111/j.1365-2249.1994.tb07007.x.
In sera of patients with mixed connective tissue disease (MCTD, Sharp Syndrome) high titres of IgG autoantibodies to U1snRNP-specific proteins are found. The isolated occurrence of these autoantibodies is highly associated with the HLA-DR4 haplotype. snRNP-specific T cells are supposed to be involved in this autoantibody production. To address this question we cultured mononuclear cells from MCTD patients and healthy donors with a highly purified UsnRNP preparation from HeLa cells using bulk or limiting dilution cultures. Secondary responses to snRNP were detected only rarely with T cell lines from two patients and two controls, and turned out to be unstable during further expansion. One T cell line derived from a healthy individual retained its snRNP reactivity upon limiting dilution cloning and could be characterized in detail. The CD4+ T cell clone recognized native snRNP particles presented by monocytes in an HLA-DR4 (B1*0401)-restricted manner. Separation of the protein and RNA moieties of snRNP particles revealed that the T cell clone responded specifically to the protein fraction, but not to RNA and diverse control antigens. Sequencing of the T cell receptor alpha and beta chain cDNAs revealed that the clone used the V alpha 14.2 and V beta 14 elements. Upon antigen-specific and mitogenic stimulation the T cell clone showed a Th1-specific cytokine pattern, and did not provide helper activity for in vitro immunoglobulin production. This study demonstrate the presence of self-reactive snRNP-specific T cells in a healthy donor. The T cell clone may not represent a helper T cell for the formation of U1snRNP-specific autoantibodies.
在混合性结缔组织病(MCTD,夏普综合征)患者的血清中,发现了针对U1snRNP特异性蛋白的高滴度IgG自身抗体。这些自身抗体的单独出现与HLA - DR4单倍型高度相关。推测snRNP特异性T细胞参与了这种自身抗体的产生。为了解决这个问题,我们使用批量或有限稀释培养法,用来自HeLa细胞的高度纯化的U snRNP制剂培养MCTD患者和健康供体的单核细胞。仅在两名患者和两名对照的T细胞系中很少检测到对snRNP的二次反应,并且在进一步扩增过程中发现其不稳定。来自一名健康个体的一个T细胞系在有限稀释克隆后保留了其snRNP反应性,并可以进行详细表征。该CD4 + T细胞克隆以HLA - DR4(B1 * 0401)限制的方式识别由单核细胞呈递的天然snRNP颗粒。snRNP颗粒的蛋白质和RNA部分的分离表明,该T细胞克隆对蛋白质部分有特异性反应,但对RNA和各种对照抗原无反应。T细胞受体α和β链cDNA的测序表明,该克隆使用了Vα14.2和Vβ14元件。在抗原特异性和有丝分裂原刺激下,该T细胞克隆表现出Th1特异性细胞因子模式,并且不提供体外免疫球蛋白产生的辅助活性。这项研究证明了健康供体中存在自身反应性snRNP特异性T细胞。该T细胞克隆可能不代表形成U1snRNP特异性自身抗体的辅助性T细胞。